PZ0012
Sunitinib malate
≥98% (HPLC), powder, receptor tyrosine kinase inhibitor
别名:
N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-2-hydroxybutanedioic acid (1:1) salt, SU 011248, SU 11248, SU112248
About This Item
推荐产品
product name
Sunitinib malate, ≥98% (HPLC)
化驗
≥98% (HPLC)
形狀
powder
溶解度
DMSO: >10 mg/mL
儲存溫度
room temp
SMILES 字串
O[C@@H](CC(O)=O)C(O)=O.CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C
InChI
1S/C22H27FN4O2.C4H6O5/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28;5-2(4(8)9)1-3(6)7/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28);2,5H,1H2,(H,6,7)(H,8,9)/b17-12-;/t;2-/m.0/s1
InChI 密鑰
LBWFXVZLPYTWQI-IPOVEDGCSA-N
基因資訊
human ... CSF1R(1436) , FLT1(2321) , FLT3(2322) , FLT4(2324) , KDR(3791) , KIT(3815) , PDGFRA(5156) , PDGFRB(5159) , RET(5979)
正在寻找类似产品? 访问 产品对比指南
應用
- to study its mechanism in the inhibition of MCF-7 cell migration and angiogenesis
- as a reference molecule to compare its docking energies with other ligands/vascular endothelial growth factor receptor (VEGF) receptor blocker
- used in proliferation assay
生化/生理作用
特點和優勢
訊號詞
Danger
危險聲明
危險分類
Repr. 1B - STOT RE 1 Oral
儲存類別代碼
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
水污染物質分類(WGK)
WGK 2
閃點(°F)
Not applicable
閃點(°C)
Not applicable
其他客户在看
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门